Volitionrx secures approximately $5.5 million in belgium regional government financing from wallonie entreprendre

Henderson, nev. , dec. 5, 2023 /prnewswire/ -- volitionrx limited (nyse american: vnrx) ("volition"), a multi-national epigenetics company, has closed on an aggregate of euro 5.0 million (approximately $5.5 million) in financing from wallonie entreprendre s.a.

VNRX Ratings Summary

VNRX Quant Ranking